Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 18;6(8):5119-5123.
doi: 10.1021/acsomega.1c00318. eCollection 2021 Mar 2.

Flavonoids in Cannabis sativa: Biosynthesis, Bioactivities, and Biotechnology

Johanna L Bautista  1 , Shu Yu  1 , Li Tian  1
Affiliations
Review

Flavonoids in Cannabis sativa: Biosynthesis, Bioactivities, and Biotechnology

Johanna L Bautista et al. ACS Omega. .

Abstract

Although Cannabis sativa synthesizes a wide range of phytochemicals, much attention has been primarily given to two phytocannabinoids, Δ9-tetrahydocannabinol (THC) and cannabidiol (CBD), due to their distinctive activities in humans. These bioactivities can be further enhanced through the interaction of THC and CBD with other phytocannabinoids or non-phytocannabinoid chemicals, such as terpenes and flavonoids, a phenomenon that is termed the entourage effect. Flavonoid metabolism in C. sativa and the entourage effect are currently understudied. This mini-review examines recent advances in the biosynthesis and bioactivities of cannflavins, which are prenylated (C5) and geranylated (C10) flavones that are relatively unique to C. sativa. We also discuss the rapidly developing omics tools that enable discoveries in flavonoid metabolism in C. sativa and manipulation of flavonoid production through biotechnology. These advances set the stage for interrogating the health benefits of C. sativa flavonoids, deciphering the contribution of flavonoids to the entourage effect, and developing drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Flavonoids in Cannabis sativa. A. Chemical structures of cannflavins and selected flavones. Cannflavin A, B, and C are present in C. sativa tissues and isocannflavin B is chemically synthesized. B. Simplified scheme of reactions leading to flavone and flavonol biosynthesis in C. sativa. PAL, phenylalanine ammonia-lyase; C4H, cinnamate 4-hydroxylase; 4CL, p-coumaroyl: CoA ligase; CHS, chalcone synthase; CHI, chalcone isomerase; F3H, flavanone 3-hydroxylase; FNS, flavone synthase; F3′H, flavonoid 3′-hydroxylase; F3′5′H, flavonoid 3′5′-hydroxylase; FLS, flavonol synthase; OMT, O-methyltransferase; PT, prenyltransferase.
See this image and copyright information in PMC

References

    1. McPartland J. M. Cannabis systematics at the levels of family, genus, and species. Cannabis Cannabinoid Res. 2018, 3, 203–212. 10.1089/can.2018.0039. - DOI - PMC - PubMed
    1. Hazekamp A.; Fischedick J. T. Cannabis - from cultivar to chemovar. Drug Test. Anal. 2012, 4, 660–667. 10.1002/dta.407. - DOI - PubMed
    1. Pollastro F.; Minassi A.; Fresu L. G. Cannabis phenolics and their bioactivities. Curr. Med. Chem. 2018, 25, 1160–1185. 10.2174/0929867324666170810164636. - DOI - PubMed
    1. Ben-Shabat S.; Fride E.; Sheskin T.; Tamiri T.; Rhee M. H.; Vogel Z.; Bisogno T.; De Petrocellis L.; Di Marzo V.; Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol. 1998, 353, 23–31. 10.1016/S0014-2999(98)00392-6. - DOI - PubMed
    1. Flores-Sanchez I. J.; Verpoorte R. Secondary metabolism in cannabis. Phytochem. Rev. 2008, 7, 615–639. 10.1007/s11101-008-9094-4. - DOI